Clinical Trial Update: Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer

View source ↗

Summary

The clinical trial update indicates that radiotherapy delays the start of second-line drug therapy in patients with oligo-progressive hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Hepatocellular Carcinoma, Radiotherapy | Status: RECRUITING